Bettina Hansen
0000-0001-8307-3341
Leiden University Medical Centre
404 papers found
Refreshing results…
A Randomized Controlled Study of Accelerated Versus Standard Hepatitis B Vaccination in HIV-Positive Patients
Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
Endoscopic visible light spectroscopy: a new, minimally invasive technique to diagnose chronic GI ischemia
Long-term survival after perforated diverticulitis
Presence of Precore and Core Promoter Mutants Limits the Probability of Achieving a Sustained Virological Response to Peginterferon in Hbeag-Positive Chronic Hepatitis B
Nonalcoholic Fatty Liver Disease Is Not Associated With Cognitive Impairment in Elderly: Results of a Population-Based Study
A Prognostic Model to Select Patients for Prophylactic Ssri Therapy During Antiviral Treatment for Chronic Hepatitis C Infection
Quantitative HBV-Dna and Ast Are Strong Predictors for Survival After Detection of Hepatocellular Carcinoma
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype
Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients
Chronic Hepatitis C Genotype 1 Infection: The Economic Need for Early Intervention With Antiviral Therapy
Tenofovir Treatment for Up to Eight Years Results in Pronounced Hbsag Decline in Hbeag-Positive Hiv/HBV Co-Infected Patients
Serum Levels of Interferon-Gamma Inducible Protein (Ip-)10 Are Associated With Response to Peginterferon Treatment in Genotype D Hbeag-Negative Chronic Hepatitis B
Peginterferon Treatment Reduces Intrahepatic Hbsag and Hbcag Expression in Patients With Hbeag-Negative Chronic Hepatitis B: Relation to Serum Hbsag Decline and Long-Term Response
Circulating Hepatocyte-Derived Micrornas Are Highly Sensitive Biomarkers Associated With the Necro-Inflammation Level in Chronic Hepatitis C Patients
Hbsag Levels at Six Months Post-Treatment Predict Sustained Response Through Long-Term Follow-Up in Hbeag-Positive Patients Treated With Peginterferon Alfa-2b
Predictiveness of Wash-Out Time Intensity Curve on Hepatocellular Carcinoma Recurrence
Monitoring Methotrexate-Induced Hepatic Fibrosis With Transient Elastography
Missing publications? Search for publications with a matching author name.